HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 78 filers reported holding HARPOON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 5.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $39,000 | -48.7% | 7,914 | -21.6% | 0.00% | – |
| Q4 2021 | $76,000 | -5.0% | 10,100 | 0.0% | 0.00% | – |
| Q3 2021 | $80,000 | -77.7% | 10,100 | -60.9% | 0.00% | – |
| Q2 2021 | $359,000 | -16.1% | 25,860 | +26.5% | 0.00% | -100.0% |
| Q1 2021 | $428,000 | +61.5% | 20,437 | +28.2% | 0.00% | – |
| Q4 2020 | $265,000 | -2.2% | 15,942 | 0.0% | 0.00% | – |
| Q3 2020 | $271,000 | +2.3% | 15,942 | 0.0% | 0.00% | – |
| Q2 2020 | $265,000 | +105.4% | 15,942 | +43.0% | 0.00% | – |
| Q1 2020 | $129,000 | -20.9% | 11,149 | +1.2% | 0.00% | – |
| Q4 2019 | $163,000 | +5.8% | 11,018 | -2.5% | 0.00% | – |
| Q3 2019 | $154,000 | +29.4% | 11,301 | +23.8% | 0.00% | – |
| Q2 2019 | $119,000 | +213.2% | 9,131 | +129.7% | 0.00% | – |
| Q1 2019 | $38,000 | – | 3,975 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
| MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
| ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
| Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
| Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
| Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
| DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
| Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |